A well-known class of drugs used to manage type 2 diabetes and control weight could offer hope for patients who also struggle ...

Get Instant Summarized Text (Gist) Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are linked to an increased risk of thyroid cancer in the first year of treatment for type 2 diabetes ...

The drug semaglutide has been linked to a lower risk of alcoholism before, but now we have strong evidence that it really ...

The two organizations will produce educational materials about the medicine and its importance for people living ... together on a campaign to raise awareness about the importance of glucagon.

Results of a placebo-controlled trial support prior observational findings that GLP-1 agonists can help reduce alcohol ...

These drugs, called GLP1-RAs (short for glucagon-like peptide-1 receptor agonists), have been found to reduce hospital visits ...

A network meta-analysis reveals age-dependent variations in efficacy of popular diabetes drugs, with SGLT2 inhibitors showing ...

Basic science researchers at the Johns Hopkins University School of Medicine are advancing heart health research by finding ...

Formally, these drugs are known as glucagon-like peptide-1 receptor agonists ... Now, scientists at Washington University School of Medicine in St. Louis and the Veterans Affairs (VA) St. Louis ...

Veiga-Fernandes and colleagues reported on their findings in Science, in a paper titled “Neuronal-ILC2 interactions regulate pancreatic glucagon and glucose homeostasis.” In their report the ...

By increasing the abundance of this one gut microbe in diabetic mice, researchers led by a team at Jiangnan University in China have shown they can "orchestrate the secretion of glucagon-like ...